Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US
At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuati...
Gespeichert in:
Veröffentlicht in: | Human vaccines 2011-01, Vol.7 (1), p.12-18 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 18 |
---|---|
container_issue | 1 |
container_start_page | 12 |
container_title | Human vaccines |
container_volume | 7 |
creator | Shen, Angela K Sobzcyk, Elizabeth Buchanan, Anna Wu, Lauren Duggan-Goldstein, Sarah |
description | At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans. |
doi_str_mv | 10.4161/hv.7.1.13949 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_865185921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>865185921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2589-803fe5bb36aa0833afa40a9bd26aa1eec6ffa6092cea0d65edbfc7b1bf7df5353</originalsourceid><addsrcrecordid>eNqFkDtPwzAUhS0Eggq6MSNvLKTYSewkbFXFo1IFQylisxz7mholTrGTSvDrSR905S6-5-jTudZB6JKSUUo5vV2uR9mIjmhSpMURGsSUpxFj6fvxYafsDA1D-CT9ZCROOT9FZzGlWZ4U2QDJOajGafwsW9s4WeFpXXfO_mwlnjTuw0MIOCaU3OGx1htl3QdeS6WsA2ysk05tHNN43C57p2s7D9i6rVrML9CJkVWA4f49R4uH-9fJUzR7eZxOxrNIxSwvopwkBlhZJlxKkieJNDIlsih13BsUQHFjJCdFrEASzRno0qispKXJtGEJS87R9S535ZuvDkIrahsUVJV00HRB5JzRnBUx7cmbHal8E4IHI1be1tJ_C0rEplaxXItMULGttcev9sFdWYM-wH8l9kC0A_pTGkJpm6AsOAUHdL4E9_S2iVxp0_P8H37fbhDSt1ZVsP_JLwI5mP4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>865185921</pqid></control><display><type>article</type><title>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Shen, Angela K ; Sobzcyk, Elizabeth ; Buchanan, Anna ; Wu, Lauren ; Duggan-Goldstein, Sarah</creator><creatorcontrib>Shen, Angela K ; Sobzcyk, Elizabeth ; Buchanan, Anna ; Wu, Lauren ; Duggan-Goldstein, Sarah</creatorcontrib><description>At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.</description><identifier>ISSN: 2164-5515</identifier><identifier>ISSN: 1554-8600</identifier><identifier>EISSN: 2164-554X</identifier><identifier>EISSN: 1554-8619</identifier><identifier>DOI: 10.4161/hv.7.1.13949</identifier><identifier>PMID: 21178397</identifier><language>eng</language><publisher>United States</publisher><subject>Binding ; Biology ; Bioscience ; Calcium ; Cancer ; Cell ; Communicable Diseases - epidemiology ; Cycle ; Health Policy ; Humans ; Landes ; Organogenesis ; Proteins ; Public-Private Sector Partnerships - trends ; United States - epidemiology ; Vaccination - economics ; Vaccination - trends ; Vaccines - economics ; Vaccines - immunology</subject><ispartof>Human vaccines, 2011-01, Vol.7 (1), p.12-18</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2589-803fe5bb36aa0833afa40a9bd26aa1eec6ffa6092cea0d65edbfc7b1bf7df5353</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21178397$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Angela K</creatorcontrib><creatorcontrib>Sobzcyk, Elizabeth</creatorcontrib><creatorcontrib>Buchanan, Anna</creatorcontrib><creatorcontrib>Wu, Lauren</creatorcontrib><creatorcontrib>Duggan-Goldstein, Sarah</creatorcontrib><title>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</title><title>Human vaccines</title><addtitle>Hum Vaccin</addtitle><description>At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.</description><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>Communicable Diseases - epidemiology</subject><subject>Cycle</subject><subject>Health Policy</subject><subject>Humans</subject><subject>Landes</subject><subject>Organogenesis</subject><subject>Proteins</subject><subject>Public-Private Sector Partnerships - trends</subject><subject>United States - epidemiology</subject><subject>Vaccination - economics</subject><subject>Vaccination - trends</subject><subject>Vaccines - economics</subject><subject>Vaccines - immunology</subject><issn>2164-5515</issn><issn>1554-8600</issn><issn>2164-554X</issn><issn>1554-8619</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAUhS0Eggq6MSNvLKTYSewkbFXFo1IFQylisxz7mholTrGTSvDrSR905S6-5-jTudZB6JKSUUo5vV2uR9mIjmhSpMURGsSUpxFj6fvxYafsDA1D-CT9ZCROOT9FZzGlWZ4U2QDJOajGafwsW9s4WeFpXXfO_mwlnjTuw0MIOCaU3OGx1htl3QdeS6WsA2ysk05tHNN43C57p2s7D9i6rVrML9CJkVWA4f49R4uH-9fJUzR7eZxOxrNIxSwvopwkBlhZJlxKkieJNDIlsih13BsUQHFjJCdFrEASzRno0qispKXJtGEJS87R9S535ZuvDkIrahsUVJV00HRB5JzRnBUx7cmbHal8E4IHI1be1tJ_C0rEplaxXItMULGttcev9sFdWYM-wH8l9kC0A_pTGkJpm6AsOAUHdL4E9_S2iVxp0_P8H37fbhDSt1ZVsP_JLwI5mP4</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Shen, Angela K</creator><creator>Sobzcyk, Elizabeth</creator><creator>Buchanan, Anna</creator><creator>Wu, Lauren</creator><creator>Duggan-Goldstein, Sarah</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</title><author>Shen, Angela K ; Sobzcyk, Elizabeth ; Buchanan, Anna ; Wu, Lauren ; Duggan-Goldstein, Sarah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2589-803fe5bb36aa0833afa40a9bd26aa1eec6ffa6092cea0d65edbfc7b1bf7df5353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>Communicable Diseases - epidemiology</topic><topic>Cycle</topic><topic>Health Policy</topic><topic>Humans</topic><topic>Landes</topic><topic>Organogenesis</topic><topic>Proteins</topic><topic>Public-Private Sector Partnerships - trends</topic><topic>United States - epidemiology</topic><topic>Vaccination - economics</topic><topic>Vaccination - trends</topic><topic>Vaccines - economics</topic><topic>Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shen, Angela K</creatorcontrib><creatorcontrib>Sobzcyk, Elizabeth</creatorcontrib><creatorcontrib>Buchanan, Anna</creatorcontrib><creatorcontrib>Wu, Lauren</creatorcontrib><creatorcontrib>Duggan-Goldstein, Sarah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human vaccines</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Angela K</au><au>Sobzcyk, Elizabeth</au><au>Buchanan, Anna</au><au>Wu, Lauren</au><au>Duggan-Goldstein, Sarah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</atitle><jtitle>Human vaccines</jtitle><addtitle>Hum Vaccin</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>7</volume><issue>1</issue><spage>12</spage><epage>18</epage><pages>12-18</pages><issn>2164-5515</issn><issn>1554-8600</issn><eissn>2164-554X</eissn><eissn>1554-8619</eissn><abstract>At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.</abstract><cop>United States</cop><pmid>21178397</pmid><doi>10.4161/hv.7.1.13949</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2164-5515 |
ispartof | Human vaccines, 2011-01, Vol.7 (1), p.12-18 |
issn | 2164-5515 1554-8600 2164-554X 1554-8619 |
language | eng |
recordid | cdi_proquest_miscellaneous_865185921 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Binding Biology Bioscience Calcium Cancer Cell Communicable Diseases - epidemiology Cycle Health Policy Humans Landes Organogenesis Proteins Public-Private Sector Partnerships - trends United States - epidemiology Vaccination - economics Vaccination - trends Vaccines - economics Vaccines - immunology |
title | Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T03%3A31%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Second%20National%20Immunization%20Congress%202010:%20Addressing%20vaccine%20financing%20for%20the%20future%20in%20the%20US&rft.jtitle=Human%20vaccines&rft.au=Shen,%20Angela%20K&rft.date=2011-01-01&rft.volume=7&rft.issue=1&rft.spage=12&rft.epage=18&rft.pages=12-18&rft.issn=2164-5515&rft.eissn=2164-554X&rft_id=info:doi/10.4161/hv.7.1.13949&rft_dat=%3Cproquest_pubme%3E865185921%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=865185921&rft_id=info:pmid/21178397&rfr_iscdi=true |